FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

The FDA approved a supplemental application for Zoledronic acid submitted by Sagent Pharmaceuticals, updating regulatory labeling per the submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Hypercalcemia of Malignancy
• Multiple Myeloma
• Osteoporosis
• Paget Disease of Bone

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

SUPPL AP for ZOLEDRONIC ACID (ZOLEDRONIC ACID)